YHP2511A

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YHP2511A, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers [Phase 1]